Altogether, these data suggest that blocking Cxcr1/2 inhibits tumor initiation and progression of neoplastic astrocytes in vivo, further supporting a role for Cxcr1 signaling at the tumor-forming niche. This evidence concerns the gene CXCR1 and neoplasm.